【Description】
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The global market for Active Pharmaceutical Ingredients (API) was estimated to be worth US$ 72090 million in 2023 and is forecast to a readjusted size of US$ 113360 million by 2030 with a CAGR of 6.6% during the forecast period 2024-2030
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Active Pharmaceutical Ingredients (API), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Active Pharmaceutical Ingredients (API) by region & country, by Type, and by Application.
The Active Pharmaceutical Ingredients (API) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Pharmaceutical Ingredients (API).
Market Segmentation
By Company
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Segment by Type:
Synthetic APIs
Biotech APIs
Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Active Pharmaceutical Ingredients (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Active Pharmaceutical Ingredients (API) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
【Table of Contents】
1 Market Overview
1.1 Active Pharmaceutical Ingredients (API) Product Introduction
1.2 Global Active Pharmaceutical Ingredients (API) Market Size Forecast
1.2.1 Global Active Pharmaceutical Ingredients (API) Sales Value (2019-2030)
1.2.2 Global Active Pharmaceutical Ingredients (API) Sales Volume (2019-2030)
1.2.3 Global Active Pharmaceutical Ingredients (API) Sales Price (2019-2030)
1.3 Active Pharmaceutical Ingredients (API) Market Trends & Drivers
1.3.1 Active Pharmaceutical Ingredients (API) Industry Trends
1.3.2 Active Pharmaceutical Ingredients (API) Market Drivers & Opportunity
1.3.3 Active Pharmaceutical Ingredients (API) Market Challenges
1.3.4 Active Pharmaceutical Ingredients (API) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Active Pharmaceutical Ingredients (API) Players Revenue Ranking (2023)
2.2 Global Active Pharmaceutical Ingredients (API) Revenue by Company (2019-2024)
2.3 Global Active Pharmaceutical Ingredients (API) Players Sales Volume Ranking (2023)
2.4 Global Active Pharmaceutical Ingredients (API) Sales Volume by Company Players (2019-2024)
2.5 Global Active Pharmaceutical Ingredients (API) Average Price by Company (2019-2024)
2.6 Key Manufacturers Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Active Pharmaceutical Ingredients (API) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Active Pharmaceutical Ingredients (API)
2.9 Active Pharmaceutical Ingredients (API) Market Competitive Analysis
2.9.1 Active Pharmaceutical Ingredients (API) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Active Pharmaceutical Ingredients (API) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Synthetic APIs
3.1.2 Biotech APIs
3.2 Global Active Pharmaceutical Ingredients (API) Sales Value by Type
3.2.1 Global Active Pharmaceutical Ingredients (API) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Active Pharmaceutical Ingredients (API) Sales Value, by Type (2019-2030)
3.2.3 Global Active Pharmaceutical Ingredients (API) Sales Value, by Type (%) (2019-2030)
3.3 Global Active Pharmaceutical Ingredients (API) Sales Volume by Type
3.3.1 Global Active Pharmaceutical Ingredients (API) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Active Pharmaceutical Ingredients (API) Sales Volume, by Type (2019-2030)
3.3.3 Global Active Pharmaceutical Ingredients (API) Sales Volume, by Type (%) (2019-2030)
3.4 Global Active Pharmaceutical Ingredients (API) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 CNS
4.1.2 Cardiovascular
4.1.3 Genitourinary/Hormonal Drugs
4.1.4 Respiratory
4.1.5 Rheumatology
4.1.6 Diabetes
4.1.7 Oncology
4.1.8 Others
4.2 Global Active Pharmaceutical Ingredients (API) Sales Value by Application
4.2.1 Global Active Pharmaceutical Ingredients (API) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Active Pharmaceutical Ingredients (API) Sales Value, by Application (2019-2030)
4.2.3 Global Active Pharmaceutical Ingredients (API) Sales Value, by Application (%) (2019-2030)
4.3 Global Active Pharmaceutical Ingredients (API) Sales Volume by Application
4.3.1 Global Active Pharmaceutical Ingredients (API) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Active Pharmaceutical Ingredients (API) Sales Volume, by Application (2019-2030)
4.3.3 Global Active Pharmaceutical Ingredients (API) Sales Volume, by Application (%) (2019-2030)
4.4 Global Active Pharmaceutical Ingredients (API) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Active Pharmaceutical Ingredients (API) Sales Value by Region
5.1.1 Global Active Pharmaceutical Ingredients (API) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Active Pharmaceutical Ingredients (API) Sales Value by Region (2019-2024)
5.1.3 Global Active Pharmaceutical Ingredients (API) Sales Value by Region (2025-2030)
5.1.4 Global Active Pharmaceutical Ingredients (API) Sales Value by Region (%), (2019-2030)
5.2 Global Active Pharmaceutical Ingredients (API) Sales Volume by Region
5.2.1 Global Active Pharmaceutical Ingredients (API) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Active Pharmaceutical Ingredients (API) Sales Volume by Region (2019-2024)
5.2.3 Global Active Pharmaceutical Ingredients (API) Sales Volume by Region (2025-2030)
5.2.4 Global Active Pharmaceutical Ingredients (API) Sales Volume by Region (%), (2019-2030)
5.3 Global Active Pharmaceutical Ingredients (API) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
5.4.2 North America Active Pharmaceutical Ingredients (API) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
5.5.2 Europe Active Pharmaceutical Ingredients (API) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
5.6.2 Asia Pacific Active Pharmaceutical Ingredients (API) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
5.7.2 South America Active Pharmaceutical Ingredients (API) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
5.8.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Value
6.2.1 Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
6.3.2 United States Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Active Pharmaceutical Ingredients (API) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
6.4.2 Europe Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Active Pharmaceutical Ingredients (API) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
6.5.2 China Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Active Pharmaceutical Ingredients (API) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
6.6.2 Japan Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Active Pharmaceutical Ingredients (API) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
6.7.2 South Korea Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Active Pharmaceutical Ingredients (API) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
6.8.2 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Active Pharmaceutical Ingredients (API) Sales Value, 2019-2030
6.9.2 India Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Active Pharmaceutical Ingredients (API) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Teva
7.1.1 Teva Company Information
7.1.2 Teva Introduction and Business Overview
7.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Teva Active Pharmaceutical Ingredients (API) Product Offerings
7.1.5 Teva Recent Development
7.2 Mylan
7.2.1 Mylan Company Information
7.2.2 Mylan Introduction and Business Overview
7.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Mylan Active Pharmaceutical Ingredients (API) Product Offerings
7.2.5 Mylan Recent Development
7.3 DSM
7.3.1 DSM Company Information
7.3.2 DSM Introduction and Business Overview
7.3.3 DSM Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 DSM Active Pharmaceutical Ingredients (API) Product Offerings
7.3.5 DSM Recent Development
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Company Information
7.4.2 Aurobindo Pharma Introduction and Business Overview
7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Offerings
7.4.5 Aurobindo Pharma Recent Development
7.5 Aspen
7.5.1 Aspen Company Information
7.5.2 Aspen Introduction and Business Overview
7.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Aspen Active Pharmaceutical Ingredients (API) Product Offerings
7.5.5 Aspen Recent Development
7.6 Novartis
7.6.1 Novartis Company Information
7.6.2 Novartis Introduction and Business Overview
7.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Novartis Active Pharmaceutical Ingredients (API) Product Offerings
7.6.5 Novartis Recent Development
7.7 BASF
7.7.1 BASF Company Information
7.7.2 BASF Introduction and Business Overview
7.7.3 BASF Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 BASF Active Pharmaceutical Ingredients (API) Product Offerings
7.7.5 BASF Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Introduction and Business Overview
7.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer Active Pharmaceutical Ingredients (API) Product Offerings
7.8.5 Pfizer Recent Development
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Company Information
7.9.2 Huahai Pharmaceutical Introduction and Business Overview
7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
7.9.5 Huahai Pharmaceutical Recent Development
7.10 Hisun Pharmaceutical
7.10.1 Hisun Pharmaceutical Company Information
7.10.2 Hisun Pharmaceutical Introduction and Business Overview
7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
7.10.5 Hisun Pharmaceutical Recent Development
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Company Information
7.11.2 Sun Pharmaceutical Industries Introduction and Business Overview
7.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Offerings
7.11.5 Sun Pharmaceutical Industries Recent Development
7.12 Zhejiang Medicine
7.12.1 Zhejiang Medicine Company Information
7.12.2 Zhejiang Medicine Introduction and Business Overview
7.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Offerings
7.12.5 Zhejiang Medicine Recent Development
7.13 Dr. Reddy’s Laboratories
7.13.1 Dr. Reddy’s Laboratories Company Information
7.13.2 Dr. Reddy’s Laboratories Introduction and Business Overview
7.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Offerings
7.13.5 Dr. Reddy’s Laboratories Recent Development
7.14 Zhejiang NHU
7.14.1 Zhejiang NHU Company Information
7.14.2 Zhejiang NHU Introduction and Business Overview
7.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Offerings
7.14.5 Zhejiang NHU Recent Development
7.15 Bayer
7.15.1 Bayer Company Information
7.15.2 Bayer Introduction and Business Overview
7.15.3 Bayer Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Bayer Active Pharmaceutical Ingredients (API) Product Offerings
7.15.5 Bayer Recent Development
7.16 NCPC
7.16.1 NCPC Company Information
7.16.2 NCPC Introduction and Business Overview
7.16.3 NCPC Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.16.4 NCPC Active Pharmaceutical Ingredients (API) Product Offerings
7.16.5 NCPC Recent Development
7.17 AbbVie
7.17.1 AbbVie Company Information
7.17.2 AbbVie Introduction and Business Overview
7.17.3 AbbVie Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.17.4 AbbVie Active Pharmaceutical Ingredients (API) Product Offerings
7.17.5 AbbVie Recent Development
7.18 Shandong Xinhua Pharmaceutical
7.18.1 Shandong Xinhua Pharmaceutical Company Information
7.18.2 Shandong Xinhua Pharmaceutical Introduction and Business Overview
7.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
7.18.5 Shandong Xinhua Pharmaceutical Recent Development
7.19 Northeast Pharm
7.19.1 Northeast Pharm Company Information
7.19.2 Northeast Pharm Introduction and Business Overview
7.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Offerings
7.19.5 Northeast Pharm Recent Development
7.20 Harbin Pharmaceutical
7.20.1 Harbin Pharmaceutical Company Information
7.20.2 Harbin Pharmaceutical Introduction and Business Overview
7.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
7.20.5 Harbin Pharmaceutical Recent Development
7.21 LKPC
7.21.1 LKPC Company Information
7.21.2 LKPC Introduction and Business Overview
7.21.3 LKPC Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2019-2024)
7.21.4 LKPC Active Pharmaceutical Ingredients (API) Product Offerings
7.21.5 LKPC Recent Development
8 Industry Chain Analysis
8.1 Active Pharmaceutical Ingredients (API) Industrial Chain
8.2 Active Pharmaceutical Ingredients (API) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Active Pharmaceutical Ingredients (API) Sales Model
8.5.2 Sales Channel
8.5.3 Active Pharmaceutical Ingredients (API) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
【Table of Figures】
List of Tables
Table 1. Active Pharmaceutical Ingredients (API) Market Trends
Table 2. Active Pharmaceutical Ingredients (API) Market Drivers & Opportunity
Table 3. Active Pharmaceutical Ingredients (API) Market Challenges
Table 4. Active Pharmaceutical Ingredients (API) Market Restraints
Table 5. Global Active Pharmaceutical Ingredients (API) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2019-2024)
Table 7. Global Active Pharmaceutical Ingredients (API) Sales Volume by Company (2019-2024) & (Tons)
Table 8. Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Active Pharmaceutical Ingredients (API) Price by Company (2019-2024) & (USD/Ton)
Table 10. Key Manufacturers Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Active Pharmaceutical Ingredients (API) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Active Pharmaceutical Ingredients (API)
Table 13. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Active Pharmaceutical Ingredients (API) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Active Pharmaceutical Ingredients (API) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Active Pharmaceutical Ingredients (API) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Active Pharmaceutical Ingredients (API) Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global Active Pharmaceutical Ingredients (API) Sales Volume by Type (2019-2024) & (Tons)
Table 23. Global Active Pharmaceutical Ingredients (API) Sales Volume by Type (2025-2030) & (Tons)
Table 24. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Active Pharmaceutical Ingredients (API) Price by Type (2019-2024) & (USD/Ton)
Table 27. Global Active Pharmaceutical Ingredients (API) Price by Type (2025-2030) & (USD/Ton)
Table 28. Global Active Pharmaceutical Ingredients (API) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Active Pharmaceutical Ingredients (API) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Active Pharmaceutical Ingredients (API) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Active Pharmaceutical Ingredients (API) Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
Table 34. Global Active Pharmaceutical Ingredients (API) Sales Volume by Application (2019-2024) & (Tons)
Table 35. Global Active Pharmaceutical Ingredients (API) Sales Volume by Application (2025-2030) & (Tons)
Table 36. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Active Pharmaceutical Ingredients (API) Price by Application (2019-2024) & (USD/Ton)
Table 39. Global Active Pharmaceutical Ingredients (API) Price by Application (2025-2030) & (USD/Ton)
Table 40. Global Active Pharmaceutical Ingredients (API) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Active Pharmaceutical Ingredients (API) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Active Pharmaceutical Ingredients (API) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Active Pharmaceutical Ingredients (API) Sales Value by Region (2019-2024) & (%)
Table 44. Global Active Pharmaceutical Ingredients (API) Sales Value by Region (2025-2030) & (%)
Table 45. Global Active Pharmaceutical Ingredients (API) Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
Table 46. Global Active Pharmaceutical Ingredients (API) Sales Volume by Region (2019-2024) & (Tons)
Table 47. Global Active Pharmaceutical Ingredients (API) Sales Volume by Region (2025-2030) & (Tons)
Table 48. Global Active Pharmaceutical Ingredients (API) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Active Pharmaceutical Ingredients (API) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Active Pharmaceutical Ingredients (API) Average Price by Region (2019-2024) & (USD/Ton)
Table 51. Global Active Pharmaceutical Ingredients (API) Average Price by Region (2025-2030) & (USD/Ton)
Table 52. Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Volume, (2019-2024) & (Tons)
Table 56. Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Volume, (2025-2030) & (Tons)
Table 57. Teva Company Information
Table 58. Teva Introduction and Business Overview
Table 59. Teva Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 60. Teva Active Pharmaceutical Ingredients (API) Product Offerings
Table 61. Teva Recent Development
Table 62. Mylan Company Information
Table 63. Mylan Introduction and Business Overview
Table 64. Mylan Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 65. Mylan Active Pharmaceutical Ingredients (API) Product Offerings
Table 66. Mylan Recent Development
Table 67. DSM Company Information
Table 68. DSM Introduction and Business Overview
Table 69. DSM Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 70. DSM Active Pharmaceutical Ingredients (API) Product Offerings
Table 71. DSM Recent Development
Table 72. Aurobindo Pharma Company Information
Table 73. Aurobindo Pharma Introduction and Business Overview
Table 74. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 75. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Offerings
Table 76. Aurobindo Pharma Recent Development
Table 77. Aspen Company Information
Table 78. Aspen Introduction and Business Overview
Table 79. Aspen Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 80. Aspen Active Pharmaceutical Ingredients (API) Product Offerings
Table 81. Aspen Recent Development
Table 82. Novartis Company Information
Table 83. Novartis Introduction and Business Overview
Table 84. Novartis Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 85. Novartis Active Pharmaceutical Ingredients (API) Product Offerings
Table 86. Novartis Recent Development
Table 87. BASF Company Information
Table 88. BASF Introduction and Business Overview
Table 89. BASF Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 90. BASF Active Pharmaceutical Ingredients (API) Product Offerings
Table 91. BASF Recent Development
Table 92. Pfizer Company Information
Table 93. Pfizer Introduction and Business Overview
Table 94. Pfizer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 95. Pfizer Active Pharmaceutical Ingredients (API) Product Offerings
Table 96. Pfizer Recent Development
Table 97. Huahai Pharmaceutical Company Information
Table 98. Huahai Pharmaceutical Introduction and Business Overview
Table 99. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 100. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
Table 101. Huahai Pharmaceutical Recent Development
Table 102. Hisun Pharmaceutical Company Information
Table 103. Hisun Pharmaceutical Introduction and Business Overview
Table 104. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 105. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
Table 106. Hisun Pharmaceutical Recent Development
Table 107. Sun Pharmaceutical Industries Company Information
Table 108. Sun Pharmaceutical Industries Introduction and Business Overview
Table 109. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 110. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Offerings
Table 111. Sun Pharmaceutical Industries Recent Development
Table 112. Zhejiang Medicine Company Information
Table 113. Zhejiang Medicine Introduction and Business Overview
Table 114. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 115. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Offerings
Table 116. Zhejiang Medicine Recent Development
Table 117. Dr. Reddy’s Laboratories Company Information
Table 118. Dr. Reddy’s Laboratories Introduction and Business Overview
Table 119. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 120. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Offerings
Table 121. Dr. Reddy’s Laboratories Recent Development
Table 122. Zhejiang NHU Company Information
Table 123. Zhejiang NHU Introduction and Business Overview
Table 124. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 125. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Offerings
Table 126. Zhejiang NHU Recent Development
Table 127. Bayer Company Information
Table 128. Bayer Introduction and Business Overview
Table 129. Bayer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 130. Bayer Active Pharmaceutical Ingredients (API) Product Offerings
Table 131. Bayer Recent Development
Table 132. NCPC Company Information
Table 133. NCPC Introduction and Business Overview
Table 134. NCPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 135. NCPC Active Pharmaceutical Ingredients (API) Product Offerings
Table 136. NCPC Recent Development
Table 137. AbbVie Company Information
Table 138. AbbVie Introduction and Business Overview
Table 139. AbbVie Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 140. AbbVie Active Pharmaceutical Ingredients (API) Product Offerings
Table 141. AbbVie Recent Development
Table 142. Shandong Xinhua Pharmaceutical Company Information
Table 143. Shandong Xinhua Pharmaceutical Introduction and Business Overview
Table 144. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 145. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
Table 146. Shandong Xinhua Pharmaceutical Recent Development
Table 147. Northeast Pharm Company Information
Table 148. Northeast Pharm Introduction and Business Overview
Table 149. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 150. Northeast Pharm Active Pharmaceutical Ingredients (API) Product Offerings
Table 151. Northeast Pharm Recent Development
Table 152. Harbin Pharmaceutical Company Information
Table 153. Harbin Pharmaceutical Introduction and Business Overview
Table 154. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 155. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
Table 156. Harbin Pharmaceutical Recent Development
Table 157. LKPC Company Information
Table 158. LKPC Introduction and Business Overview
Table 159. LKPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2019-2024)
Table 160. LKPC Active Pharmaceutical Ingredients (API) Product Offerings
Table 161. LKPC Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Active Pharmaceutical Ingredients (API) Downstream Customers
Table 165. Active Pharmaceutical Ingredients (API) Distributors List
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharmaceutical Ingredients (API) Product Picture
Figure 2. Global Active Pharmaceutical Ingredients (API) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Active Pharmaceutical Ingredients (API) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Active Pharmaceutical Ingredients (API) Sales Volume (2019-2030) & (Tons)
Figure 5. Global Active Pharmaceutical Ingredients (API) Sales Price (2019-2030) & (USD/Ton)
Figure 6. Active Pharmaceutical Ingredients (API) Report Years Considered
Figure 7. Global Active Pharmaceutical Ingredients (API) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Active Pharmaceutical Ingredients (API) Players Sales Volume Ranking (2023) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2023
Figure 10. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Synthetic APIs Picture
Figure 12. Biotech APIs Picture
Figure 13. Global Active Pharmaceutical Ingredients (API) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Active Pharmaceutical Ingredients (API) Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Active Pharmaceutical Ingredients (API) Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
Figure 16. Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Active Pharmaceutical Ingredients (API) Price by Type (2019-2030) & (USD/Ton)
Figure 18. Product Picture of CNS
Figure 19. Product Picture of Cardiovascular
Figure 20. Product Picture of Genitourinary/Hormonal Drugs
Figure 21. Product Picture of Respiratory
Figure 22. Product Picture of Rheumatology
Figure 23. Product Picture of Diabetes
Figure 24. Product Picture of Oncology
Figure 25. Product Picture of Others
Figure 26. Global Active Pharmaceutical Ingredients (API) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Active Pharmaceutical Ingredients (API) Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Active Pharmaceutical Ingredients (API) Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 29. Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Active Pharmaceutical Ingredients (API) Price by Application (2019-2030) & (USD/Ton)
Figure 31. North America Active Pharmaceutical Ingredients (API) Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Active Pharmaceutical Ingredients (API) Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Active Pharmaceutical Ingredients (API) Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Active Pharmaceutical Ingredients (API) Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Active Pharmaceutical Ingredients (API) Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Active Pharmaceutical Ingredients (API) Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Active Pharmaceutical Ingredients (API) Sales Volume (%), (2019-2030)
Figure 43. United States Active Pharmaceutical Ingredients (API) Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Active Pharmaceutical Ingredients (API) Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Active Pharmaceutical Ingredients (API) Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Active Pharmaceutical Ingredients (API) Sales Value by Application (%), 2023 VS 2030
Figure 49. China Active Pharmaceutical Ingredients (API) Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
Figure 51. China Active Pharmaceutical Ingredients (API) Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Active Pharmaceutical Ingredients (API) Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Active Pharmaceutical Ingredients (API) Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Active Pharmaceutical Ingredients (API) Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Active Pharmaceutical Ingredients (API) Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Value by Application (%), 2023 VS 2030
Figure 61. India Active Pharmaceutical Ingredients (API) Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Active Pharmaceutical Ingredients (API) Sales Value by Type (%), 2023 VS 2030
Figure 63. India Active Pharmaceutical Ingredients (API) Sales Value by Application (%), 2023 VS 2030
Figure 64. Active Pharmaceutical Ingredients (API) Industrial Chain
Figure 65. Active Pharmaceutical Ingredients (API) Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed